HIV Limited / Population Age Group / Cox / Case / M.D. / /
Country
United States / Panama / New Caledonia / /
Currency
USD / /
Event
FDA Phase / /
Facility
Laboratory Diagnosis / /
IndustryTerm
age / cardiovascular systems / risk / otitis media / Manufacturing processes / preventive services / preventive medical services / influenza-associated otitis media / /
MedicalCondition
influenza-related respiratory illness / HIV / headache / Epidemic / lung diseases / influenza epidemics / chronic heart / heart disease / rhinitis / influenza illness / certain chronic diseases / acute pulmonary conditions / primary influenza viral pneumonia / different U.S. epidemics / lung disease / influenza-associated otitis media / severe illness / Persons Who Can Transmit Influenza / certain chronic medical conditions / seasonal epidemics / epidemics / influenza virus / otitis media / different influenza epidemics / secondary bacterial pneumonia / illness / myocarditis / renal dysfunction / influenza / vaccine and circulating influenza / influenza respiratory illness / pericarditis / Influenza Vaccine Composition Influenza / Both influenza A / asthma / hemoglobinopathies / HIV infection / encephalopathy / transverse myelitis / chronic disorders / sore throat / epidemic type A / pneumonia / vaccine and epidemic strains / Influenza infection / disease / epidemic human disease / pulmonary conditions / chronic / Reye syndrome / Influenza A / Introduction Epidemics / stroke / reduced thimerosal-content influenza / trivalent inactivated influenza / coughing / diabetes / influenza-related upper respiratory tract infection / trivalent influenza / fever / allergy / diabetes mellitus / Rickettsial Diseases / myositis / diseases / influenza viruses / cardiac disease / AIDS / Influenza Influenza / excess pneumonia / each year’s influenza / infection / chronic medical conditions / chronic metabolic diseases / culture-confirmed influenza / cough / Influenza Influenza A / respiratory disease / spontaneous abortion / serious illness / either pneumonia / Influenza B / Influenza Vaccine Influenza / /
U.S. Department of Health and Human Services / U.S. Public Health Service / Health Maintenance Organization / National Center for Infectious Diseases / Simultaneous Administration / Centers for Disease Control and Prevention / Medicare / Advisory Committee on Immunization Practices / Epidemiology and Surveillance Division / Division of Viral / U.S. Food and Drug Administration / Epidemiology Program Office / /
Person
Lynda G. Cupell Beverly / Dixie E. Snider / C. Kay Smith-Akin / James W. LeDuc / John W. Ward / Evans Vaccines / Stephen B. Thacker / James M. Hughes / Melinda Wharton / Erica R. Shaver / Michele D. Renshaw Erica / Walter A. Orenstein / Effect / Burden / Carolyn B. Bridges / Suzanne M. Hewitt / David W. Fleming / /
Position
Editor / physician / Director Editor / Acting Director / Director / Associate Director / Acting Director and Deputy Director / Managing Editor / representative / Director Role / Director and Deputy Director / /
Product
Antiviral Drug / Influenza vaccine / /
ProvinceOrState
Tennessee / Georgia / /
Technology
Pharmacokinetics / 22 Lynda G. Cupell Beverly J. Holland Visual Information Specialists Michele D. Renshaw Erica R. Shaver Information Technology / /
Please note: An erratum has been published for this issue. To view the erratum, please click here. Morbidity and Mortality Weekly Report Recommendations and Reports April 12, [removed]Vol[removed]No. RR-3